Live Breaking News & Updates on James Sapirstein|Page 5

Stay updated with breaking news from James sapirstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

First Wave BioPharma CEO James Sapirstein to Present at the 2023 Roth Healthcare Opportunities Conference

First Wave BioPharma CEO James Sapirstein to Present at the 2023 Roth Healthcare Opportunities Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Boca Raton , James Sapirstein , David Schemelia , First Wave Biopharma Inc , Yale Club , Healthcare Opportunities , Wave Biopharma , First Wave Biopharma , Healthcare Opportunities Conference , Healthcare Oppotunities , Tap Room , First Wave ,

First Wave BioPharma CEO James Sapirstein to Present at the 2023 Roth Healthcare Opportunities Conference - First Wave BioPharma (NASDAQ:FWBI)

BOCA RATON, Fla., Oct. 03, 2023 (GLOBE NEWSWIRE) First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of ....

New York , United States , Boca Raton , James Sapirstein , First Wave Biopharma Inc , Wave Biopharma , First Wave Biopharma , Healthcare Opportunities Conference , First Wave ,

First Wave BioPharma To Present at the BIO Investor Forum

First Wave BioPharma To Present at the BIO Investor Forum
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Boca Raton , United States , San Francisco , James Sapirstein , David Schemelia , First Wave Biopharma Inc , First Wave Bio Inc , Company Annual Report On Form , Investor Forum , Hilton San Francisco Union Square , Tiberend Strategic Advisors Inc , Exchange Commission , Wave Biopharma , First Wave Biopharma , First Wave , First Wave Bio , Annual Report , Strategic Advisors ,

'Transformative Event' For First Wave BioPharma: License Agreement for Hopeful Gastrointestinal Candidate From Sanofi - First Wave BioPharma (NASDAQ:FWBI), Sanofi (NASDAQ:SNY)

First Wave BioPharma Inc (NASDAQ: FWBI) announced an agreement with Sanofi SA (NASDAQ: SNY) to license Capeserod, a selective 5-HT4 receptor partial agonist, which First Wave will repurpose and develop for ....

Biopharma Inc , James Sapirstein , First Wave Biopharma , First Wave ,

First Wave BioPharma (FWBI) Enters Exclusive Global License Agreement for Capeserod from Sanofi (SNY)

First Wave BioPharma (FWBI) Enters Exclusive Global License Agreement for Capeserod from Sanofi (SNY)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Boca Raton , United States , David Schemelia , James Sapirstein , First Wave Bio Inc , Exchange Commission , Drug Administration , Tiberend Strategic Advisors Inc , Company Annual Report On Form , First Wave Biopharma Inc , First Wave Biopharma , First Wave , Wave Biopharma , First Wave Bio , Annual Report , Strategic Advisors ,